David Huron is an accomplished professional in the field of oncology with significant experience in medical affairs and leadership roles. Currently serving as the Executive Medical Director and Thoracic Oncology Platform Lead at Amgen since March 2022, David previously held positions at Kite Pharma as the US Medical Affairs YESCARTA Lead and at Bristol-Myers Squibb as the US Medical Lead for Immuno-Oncology focusing on lung cancer and biomarkers. Additional experience includes a tenure at FCB Health as SVP and VP of Medical Director and a position as Director of Content Strategy at Evea, Inc. David Huron holds a PhD in Pharmacology from Joan & Sanford I. Weill Medical College of Cornell University and a BS in Biochemistry from Texas Tech University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices